C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
about
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsCpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury.PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi InfectionEfficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsProgress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9.CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.TLR9 in health and disease.Immunostimulatory DNA as a vaccine adjuvant.Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species.Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.Immunosenescence in persons with spinal cord injury in relation to urinary tract infections -a cross-sectional study.Increased motility of mesenchymal stem cells is correlated with inhibition of stimulated peripheral blood mononuclear cells in vitro.A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
P2860
Q28972540-215BB926-B146-40A7-9E11-43B69573D4B7Q33944310-120E6EAF-9B57-4117-B6FE-B3B3D966EEEDQ34785434-37A2B79C-CFA2-4DC7-B31C-33887DA39B88Q35113433-1A2B495C-7118-43ED-AA4B-10A4A528DAA9Q35155756-152248F9-E3C9-4587-A827-B1472ADB3B15Q35651568-30AFDBF9-BB4C-4142-9D53-2750F5120AE9Q35677724-78378567-2EBF-4174-AA36-2060FFC39D30Q36150499-29E3AB0C-3B15-4F12-B2D7-BEC62B2E02B8Q36378325-7674C7FA-E3DD-41C6-B1D0-C4B5FE34FBB9Q36526346-D0DAABD5-DC64-45E7-A7B9-E6B8264640FFQ36968274-E7C6DE63-1C6B-4D0B-BFFF-58DEE6B91FABQ38131836-CB40C537-A16A-483A-B3B8-2DD9B1E7306BQ38336408-60F021C0-A2C5-4CD3-8B18-1F6E3936CB13Q47108782-FA290877-2261-47F5-87E5-A5C7803D74DBQ48503911-95B3767D-73F6-4633-96CD-7708625AC1F5Q56787248-A46307C6-1797-474F-9163-6A88CF66DDD2
P2860
C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@en
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@nl
type
label
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@en
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@nl
prefLabel
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@en
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@nl
P2093
P1433
P1476
C-Class CpG ODN: sequence requ ...... tory activities on mRNA level.
@en
P2093
Andrea Kritzler
Arthur M Krieg
Bernhard Noll
Bettina Schulte
Christian Schetter
Eugen Uhlmann
Jörg Vollmer
Marion Jurk
Tanja Wader
P304
P356
10.1016/J.IMBIO.2004.02.006
P577
2004-01-01T00:00:00Z